Source: Eur Respir J, 55 (2) 1901812; 10.1183/13993003.01812-2019
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
David C. LaFon, Surya P. Bhatt, Wassim W. Labaki, Farbod N. Rahaghi, Matthew Moll, Russ P. Bowler, Elizabeth A. Regan, Barry J. Make, James D. Crapo, Raul San Jose Estepar, Alejandro A. Diaz, Edwin K. Silverman, MeiLan K. Han, Brian Hobbs, Michael H. Cho, George R. Washko, Mark T. Dransfield, J. Michael Wells. Pulmonary artery enlargement and mortality risk in moderate to severe COPD: results from COPDGene. Eur Respir J, 55 (2) 1901812; 10.1183/13993003.01812-2019

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Chronic coronary artery disease and decline of lung function as predictors of mortality and exacerbation risk in stable COPD: Results from COSYCONET Source: Virtual Congress 2021 – Lung function evaluation and assessment of airway diseases Year: 2021 Pulmonary artery hypertension and severity of airflow limitation in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 657s Year: 2006 Pulmonary artery to aorta ratio and mortality risk in the general population: The Rotterdam study Source: International Congress 2016 – Imaging of COPD and airways: structural and functional assessments Year: 2016 Pulmonary vascular resistance predicts mortality in patients with pulmonary hypertension associated with interstitial lung disease: results from the COMPERA registry Source: Eur Respir J, 58 (2) 2101483; 10.1183/13993003.01483-2021 Year: 2021 Pulmonary vascular disease(PC) and risk of mortality in patients with idiopathic pulmonary fibrosis(IPF) Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies Year: 2018 CT predictors of pulmonary hypertension in patients with severe COPD Source: International Congress 2018 – Evaluation of COPD and various diseases by different imaging modalities Year: 2018 Chronic obstructive pulmonary disease (COPD) exacerbations and carotid artery plaques: The Rotterdam study Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts Year: 2013 The prevalence and characteristics of pulmonary hypertension in severe COPD Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Risk assessment in severe pulmonary hypertension due to interstitial lung disease Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Comparison of CT scan-measured pulmonary artery to aorta ratio of combined pulmonary fibrosis and emphysema (CPFE) and COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Impact of exacerbations on pulmonary arterial enlargement in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Chronic thromboembolic pulmonary hypertension in acute pulmonary embolism: A risk factor evaluation study Source: Virtual Congress 2020 – Pulmonary embolism Year: 2020 Pulmonary hypertension in COPD: results from the ASPIRE registry Source: Eur Respir J 2013; 41: 1292-1301 Year: 2013 Macitentan reduces the risk of morbidity and mortality irrespective of the presence or absence of right ventricular (RV) impairment: Results from the randomised SERAPHIN trial in pulmonary arterial hypertension (PAH) Source: International Congress 2014 – Pulmonary hypertension: improving treatment in PAH Year: 2014 COPD is associated with an increased risk of peripheral artery disease and mortality Source: ERJ Open Res, 4 (4) 00086-2018; 10.1183/23120541.00086-2018 Year: 2018 Severe pulmonary sarcoidosis: definition and risk stratification Source: Virtual Congress 2020 – Severe thoracic sarcoidosis : where do we stand ? Year: 2020 Hospitalization in patients with pulmonary arterial hypertension: causes and outcomes Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Prognostic impact of chronic obstructive pulmonary disease in severe symptomatic aortic stenosis Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities Year: 2016 Usefulness of admission red cell distribution Width as a predictor of early mortality in patients with severe exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD Source: Eur Respir J 2002; 19: 632-638 Year: 2002